脱毛
发表于 2025-3-25 06:37:59
http://reply.papertrans.cn/83/8241/824084/824084_21.png
窝转脊椎动物
发表于 2025-3-25 08:47:09
http://reply.papertrans.cn/83/8241/824084/824084_22.png
使隔离
发表于 2025-3-25 12:30:42
Tailoring Kinetics of Antibodies Using Focused Combinatorial Librariesof binding virtually any molecule including proteins, carbohydrates, nucleic acids, and haptens. The intrinsic features of specificity and affinity when combined offer a great advantage in the discovery of a wide-range of lead drug candidates.
高贵领导
发表于 2025-3-25 16:32:06
Humanization of Monoclonal Antibodies by CDR GraftingThe discovery of the process for making rodent monoclonal antibodies (MAbs) 26 years ago by Kohler and Milstein has led to a revolution in the treatment of over 50 major diseases, and has borne an industry whose products today represent 6% of total biotechnology sales. The full potential of this industry has still to be reached.
和平
发表于 2025-3-25 23:01:21
Recombinant Single-Chain and Disulfide-Stabilized Fv Immunotoxins for Cancer TherapyThe rapid progress in understanding the molecular biology of cancer cells has made a large impact on the design and development of novel therapeutic strategies.
Amnesty
发表于 2025-3-26 03:06:34
http://reply.papertrans.cn/83/8241/824084/824084_26.png
使迷惑
发表于 2025-3-26 05:05:37
http://reply.papertrans.cn/83/8241/824084/824084_27.png
Aggregate
发表于 2025-3-26 09:04:51
Recombinant Antibodies for Cancer Therapy978-1-59259-334-7Series ISSN 1064-3745 Series E-ISSN 1940-6029
Detonate
发表于 2025-3-26 14:23:34
Single-Domain VH Antibody Fragments from a Phage Display Libraryng any given molecular entity (antigen). Antigen recognition is conferred to the antibody by a limited number of hypervariable surface loops, differing in sequence and in length, which are connected to a conserved framework structure.
改革运动
发表于 2025-3-26 18:32:02
1064-3745 s step-by-step. Moreover, each protocol supplies a troubleshooting guide containing detailed information on possible problems and hints for pot- tial solutions. Antibody technology is a subject978-1-61737-250-6978-1-59259-334-7Series ISSN 1064-3745 Series E-ISSN 1940-6029